Every round on record, with the sources behind each and the investors on them.
A non-invasive AI brain-computer interface company
bcisonics.comShanghai, ChinaHealthtechFounded 2025
4 sources · checked 2 times, last 9d ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
Sources 1 and 2 differ on some investor names, while Sources 3 and 4 identify Sequoia China and Yunqi as the leads; the latter accounts prevail. Sources 1 and 4 date the announcement September 22, while Sources 2 and 3 publish on September 23.
Financing repair: https://g-medtech.com/news/bci-sonics-raises-200-million-yuan-pre-a-round-to-advance-non-invasive-ai-brain-computer-interfaces settles the lead role; source names Sequoia China, Yunqi Partners as leads
2 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source later spells the co-lead as “Daoyuan Capital” and identifies Xun Guang Capital as the exclusive financial advisor, not an investor.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-A | $29.8M RMB 200 million | 2026-09-22 | Sequoia China, Yunqi Partners | No recent discussion |
4 sources · checked 2 times, last 9d ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 4 sources
Sources 1 and 2 differ on some investor names, while Sources 3 and 4 identify Sequoia China and Yunqi as the leads; the latter accounts prevail. Sources 1 and 4 date the announcement September 22, while Sources 2 and 3 publish on September 23. Financing repair: https://g-medtech.com/news/bci-sonics-raises-200-million-yuan-pre-a-round-to-advance-non-invasive-ai-brain-computer-interfaces settles the lead role; source names Sequoia China, Yunqi Partners as leads | ||||
BCI-Sonics builds AI-guided, non-invasive brain-computer interfaces that use low-intensity focused ultrasound to precisely modulate deep and superficial brain regions for research, clinical, and consumer applications.
BCI-Sonics is trying to solve non-invasive BCI's depth, skull-variability, and precision problems by pairing low-intensity focused ultrasound with individualized phase correction and AI closed-loop brain reading and decoding. The nearly RMB 300 million raised is funding product development, talent, clinical research, and AI infrastructure while its products move toward clinical trials and consumer validation, making the bet a push from laboratory prototypes toward hospitals and homes.
Checked against 9 sources on Sep 24
| Pre-seed angel series [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $14.7M RMB 100 million | 2026-06-08 | Matrix Partners China, Delian Capital, Dao Yuan Capital | No recent discussion |
2 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 of 2 sources
The source later spells the co-lead as “Daoyuan Capital” and identifies Xun Guang Capital as the exclusive financial advisor, not an investor. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: kucoin.com, vcbeathealth.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 of 2 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
Also named as backers in company research: HongShan, Xuhui Sci-Tech Innovation Investment, MORAL STONE INVESTMENT